{
  "schemaVersion": "1.0.0",
  "project": "Type1Cure.com",
  "generatedAt": "2026-11-04T20:17:10.764Z",
  "itemCount": 1,
  "medicalDisclaimer": "Preprints are not peer reviewed and early findings often change. This lane is for the earliest research signal, clearly labeled. It is information, not medical advice.",
  "sourceHealth": [
    {
      "sourceId": "Breakthrough T1D",
      "sourceName": "Breakthrough T1D",
      "status": "ok",
      "itemCount": 1
    },
    {
      "sourceId": "medrxiv",
      "sourceName": "medrxiv",
      "status": "ok",
      "itemCount": 0
    },
    {
      "sourceId": "EurekAlert",
      "sourceName": "EurekAlert",
      "status": "error",
      "itemCount": 0,
      "detail": "HTTP 404"
    },
    {
      "sourceId": "biorxiv",
      "sourceName": "biorxiv",
      "status": "ok",
      "itemCount": 0
    }
  ],
  "items": [
    {
      "id": "Breakthrough T1D:https://www.breakthrought1d.org/news-and-updates/advancing-ketone-monitoring-for-t1d/",
      "source": "Breakthrough T1D",
      "sourceType": "nonprofit",
      "evidenceLabel": "nonprofit update",
      "title": "From Approval to Clinical Practice: Advancing Ketone Monitoring for T1D",
      "url": "https://www.breakthrought1d.org/news-and-updates/advancing-ketone-monitoring-for-t1d/",
      "publishedAt": "2026-10-19T14:33:18.000Z",
      "category": "nonprofit",
      "summary": "The First Dual Glucose-Ketone Monitor is Approved in the U.S. You might have seen the news: the U.S. Food and Drug Administration approved Abbott’s Libre Duo 10 Day, the world’s first dual glucose-ketone sensing technology for ages 2+. Studies have shown that many people with type 1 diabetes (T1D) don’t have ketone te…",
      "tags": [
        "nonprofit",
        "nonprofit"
      ],
      "cureSignal": false
    }
  ]
}